CYTK - Cytokinetics, Incorporated

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
14.65
-0.15 (-1.01%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close14.80
Open14.90
Bid10.15 x 100
Ask0.00 x 0
Day's Range14.50 - 15.05
52 Week Range8.77 - 17.20
Volume402,408
Avg. Volume452,518
Market Cap786.22M
Beta1.92
PE Ratio (TTM)-43.22
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Implied Volatility Surging for Cytokinetics (CYTK) Stock Options
    Zacks14 days ago

    Implied Volatility Surging for Cytokinetics (CYTK) Stock Options

    Cytokinetics (CYTK) needs Investors to pay close attention to the stock based on moves in the options market lately.

  • Options Traders Expect Huge Moves in Cytokinetics (CYTK) Stock
    Zackslast month

    Options Traders Expect Huge Moves in Cytokinetics (CYTK) Stock

    Investors in Cytokinetics (CYTK) need to pay close attention to the stock based on moves in the options market lately.

  • Capital Cube2 months ago

    ETFs with exposure to Cytokinetics, Inc. : September 7, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cytokinetics, Inc. Here are 5 ETFs with the largest exposure to CYTK-US. Comparing the performance and risk of Cytokinetics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Cytokinetics, Inc. breached its 50 day moving average in a Bullish Manner : CYTK-US : August 29, 2017
    Capital Cube2 months ago

    Cytokinetics, Inc. breached its 50 day moving average in a Bullish Manner : CYTK-US : August 29, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Cytokinetics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Capital Cube2 months ago

    ETFs with exposure to Cytokinetics, Inc. : August 21, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cytokinetics, Inc. Here are 5 ETFs with the largest exposure to CYTK-US. Comparing the performance and risk of Cytokinetics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of CYTK earnings conference call or presentation 2-Aug-17 8:30pm GMT

    Q2 2017 Cytokinetics Inc Earnings Call

  • Cytokinetics, Inc. :CYTK-US: Earnings Analysis: Q2, 2017 By the Numbers : August 10, 2017
    Capital Cube2 months ago

    Cytokinetics, Inc. :CYTK-US: Earnings Analysis: Q2, 2017 By the Numbers : August 10, 2017

    Categories: Yahoo FinanceGet free summary analysis Cytokinetics, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Cytokinetics, Inc. – Ligand Pharmaceuticals Incorporated, Trevena, Inc., Acorda Therapeutics, Inc., ArQule, Inc. and Amgen Inc. (LGND-US, TRVN-US, ACOR-US, ARQL-US and AMGN-US) that have also reported for this period. ... Read more (Read more...)

  • Cytokinetics, Inc. breached its 50 day moving average in a Bearish Manner : CYTK-US : August 4, 2017
    Capital Cube3 months ago

    Cytokinetics, Inc. breached its 50 day moving average in a Bearish Manner : CYTK-US : August 4, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Cytokinetics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Associated Press3 months ago

    Cytokinetics reports 2Q loss

    The South San Francisco, California-based company said it had a loss of 60 cents per share. The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment ...

  • Capital Cube3 months ago

    Cytokinetics, Inc. – Value Analysis (NASDAQ:CYTK) : July 31, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Cytokinetics, Inc. a score of 82. Our analysis is based on comparing Cytokinetics, Inc. with the following peers – GTx, Inc., ARCA biopharma, Inc., Ligand Pharmaceuticals Incorporated, Trevena, Inc., Acorda Therapeutics, Inc., Eiger BioPharmaceuticals, Inc., Array BioPharma Inc., ArQule, Inc. and Amgen Inc. (GTXI-US, ABIO-US, LGND-US, TRVN-US, ... Read more (Read more...)

  • Cytokinetics, Inc. breached its 50 day moving average in a Bullish Manner : CYTK-US : July 17, 2017
    Capital Cube3 months ago

    Cytokinetics, Inc. breached its 50 day moving average in a Bullish Manner : CYTK-US : July 17, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Cytokinetics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Capital Cube3 months ago

    ETFs with exposure to Cytokinetics, Inc. : July 11, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cytokinetics, Inc. Here are 5 ETFs with the largest exposure to CYTK-US. Comparing the performance and risk of Cytokinetics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Cytokinetics, Inc. breached its 50 day moving average in a Bearish Manner : CYTK-US : June 27, 2017
    Capital Cube4 months ago

    Cytokinetics, Inc. breached its 50 day moving average in a Bearish Manner : CYTK-US : June 27, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Cytokinetics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Cytokinetics, Inc. breached its 50 day moving average in a Bullish Manner : CYTK-US : June 15, 2017
    Capital Cube4 months ago

    Cytokinetics, Inc. breached its 50 day moving average in a Bullish Manner : CYTK-US : June 15, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Cytokinetics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Capital Cube4 months ago

    ETFs with exposure to Cytokinetics, Inc. : June 12, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cytokinetics, Inc. Here are 5 ETFs with the largest exposure to CYTK-US. Comparing the performance and risk of Cytokinetics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Cytokinetics, Inc. :CYTK-US: Earnings Analysis: Q1, 2017 By the Numbers : June 9, 2017
    Capital Cube4 months ago

    Cytokinetics, Inc. :CYTK-US: Earnings Analysis: Q1, 2017 By the Numbers : June 9, 2017

    Categories: Yahoo FinanceGet free summary analysis Cytokinetics, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Cytokinetics, Inc. – Ligand Pharmaceuticals Incorporated, Trevena, Inc., Acorda Therapeutics, Inc., Amgen Inc., ArQule, Inc. and Array BioPharma Inc. (LGND-US, TRVN-US, ACOR-US, AMGN-US, ARQL-US and ARRY-US) that have also ... Read more (Read more...)

  • Cytokinetics, Inc. breached its 50 day moving average in a Bullish Manner : CYTK-US : June 2, 2017
    Capital Cube5 months ago

    Cytokinetics, Inc. breached its 50 day moving average in a Bullish Manner : CYTK-US : June 2, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Cytokinetics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)

  • TheStreet.com5 months ago

    Biotech Movers: Anika Up on Strong Analyst Ratings

    Anika focuses on pain management, tissue regeneration and wound healing.

  • Thomson Reuters StreetEvents6 months ago

    Edited Transcript of CYTK earnings conference call or presentation 27-Apr-17 8:30pm GMT

    Q1 2017 Cytokinetics Inc Earnings Call

  • Zacks6 months ago

    New Strong Sell Stocks for May 4th

    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

  • TheStreet.com6 months ago

    Merger Buzz Drives Akorn to Top of Health Chart in April

    Other industry list-toppers included MiMedx, Cytokinetics, C.R. Bard, and Spectrum.

  • Associated Press6 months ago

    Cytokinetics reports 1Q loss

    The South San Francisco, California-based company said it had a loss of 62 cents per share. The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment ...

  • Capital Cube6 months ago

    ETFs with exposure to Cytokinetics, Inc. : April 24, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cytokinetics, Inc. Here are 5 ETFs with the largest exposure to CYTK-US. Comparing the performance and risk of Cytokinetics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube6 months ago

    Cytokinetics, Inc. – Value Analysis (NASDAQ:CYTK) : April 20, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Cytokinetics, Inc. a score of 93. Our analysis is based on comparing Cytokinetics, Inc. with the following peers – ARCA biopharma, Inc., Ligand Pharmaceuticals Incorporated, GTx, Inc., Trevena, Inc., Acorda Therapeutics, Inc., Amgen Inc., ArQule, Inc., Eiger BioPharmaceuticals, Inc. and Array BioPharma Inc. (ABIO-US, LGND-US, GTXI-US, TRVN-US, ... Read more (Read more...)